THE USE OF TUMOR-MARKERS IN GERM-CELL MALIGNANCIES

被引:11
作者
BOSL, GJ
CHAGANTI, RSK
机构
[1] MEM SLOAN KETTERING CANC CTR, DEPT PATHOL, CYTOGENET SERV, NEW YORK, NY 10021 USA
[2] CORNELL UNIV, COLL MED, DEPT MED, NEW YORK, NY 10021 USA
[3] CORNELL UNIV, COLL MED, GRAD SCH MED SCI, NEW YORK, NY 10021 USA
关键词
D O I
10.1016/S0889-8588(18)30169-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:573 / 587
页数:15
相关论文
共 96 条
[1]  
AHMED T, 1985, CANCER, V56, P860, DOI 10.1002/1097-0142(19850815)56:4<860::AID-CNCR2820560426>3.0.CO
[2]  
2-3
[4]   COMPARISON OF CRITERIA FOR ASSIGNING GERM-CELL TUMOR PATIENTS TO GOOD RISK AND POOR RISK STUDIES [J].
BAJORIN, D ;
KATZ, A ;
CHAN, E ;
GELLER, N ;
VOGELZANG, N ;
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :786-792
[5]  
BATTIFORA H, 1984, CANCER, V54, P843, DOI 10.1002/1097-0142(19840901)54:5<843::AID-CNCR2820540514>3.0.CO
[6]  
2-G
[7]   PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS [J].
BIRCH, R ;
WILLIAMS, S ;
CONE, A ;
EINHORN, L ;
ROARK, P ;
TURNER, S ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :400-407
[8]  
BOSL GJ, 1983, CANCER RES, V43, P3403
[9]  
BOSL GJ, 1991, CANCER, V67, P1299, DOI 10.1002/1097-0142(19910301)67:5<1299::AID-CNCR2820670505>3.0.CO
[10]  
2-4